Safety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka

dc.contributor.authorSanchayan, K.
dc.contributor.authorFernandopulle, R.
dc.contributor.authorAmarasinghe, A.
dc.contributor.authorThiyahiny, S.N.
dc.contributor.authorSri Ranganathan, S.
dc.date.accessioned2019-02-21T05:25:00Z
dc.date.available2019-02-21T05:25:00Z
dc.date.issued2016-09
dc.identifier.citationThe Ceylon Medical Journal, 61(3):p.99-105
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/24386
dc.publisherThe Sri Lanka Medical Association:Colombo
dc.subjectAdverse events following immunisation
dc.subjectCohort event monitoring
dc.subjectLive attenuated Japanese encephalitis vaccine
dc.subjectVaccine safety
dc.titleSafety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
CMJ_61_3_99.pdf
Size:
45.63 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Plain Text
Description: